The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer.
Cho-Han ChiangCho-Hung ChiangYuan Ping HsiaAunchalee JaroenlapnopparatChuan-Sheng HorngKit Yee WongShih-Syuan WangYu-Cheng ChangBrian Shiian ChenYu-Ze LuanChun-Hao WangTomas G NeilanCho-Hsien ChiangCheng-Ming PengHer-Shyong ShiahPublished in: Journal of gastroenterology and hepatology (2024)
SGLT2i were associated with a higher rate of survival in T2DM patients with colorectal cancer.